MGO One Seven’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.46M Buy
50,154
+32,432
+183% +$2.24M 0.11% 204
2025
Q1
$1.23M Sell
17,722
-2,344
-12% -$163K 0.05% 386
2024
Q4
$1.73M Buy
20,066
+2,413
+14% +$208K 0.07% 305
2024
Q3
$2.1M Sell
17,653
-2,146
-11% -$256K 0.09% 241
2024
Q2
$2.83M Buy
19,799
+3,629
+22% +$518K 0.13% 175
2024
Q1
$2.08M Sell
16,170
-1,460
-8% -$187K 0.11% 212
2023
Q4
$1.82M Buy
17,630
+600
+4% +$62.1K 0.1% 215
2023
Q3
$1.55M Buy
17,030
+1,436
+9% +$131K 0.12% 192
2023
Q2
$1.26M Sell
15,594
-912
-6% -$73.8K 0.12% 209
2023
Q1
$1.31M Buy
16,506
+734
+5% +$58.4K 0.08% 254
2022
Q4
$1.07M Buy
15,772
+150
+1% +$10.2K 0.11% 215
2022
Q3
$778 Sell
15,622
-1,646
-10% -$82 0.03% 290
2022
Q2
$962K Sell
17,268
-9,156
-35% -$510K 0.13% 179
2022
Q1
$1.13M Sell
26,424
-376
-1% -$16.1K 0.12% 193
2021
Q4
$1.16M Buy
26,800
+2,064
+8% +$89.4K 0.12% 203
2021
Q3
$1.03M Buy
24,736
+2,216
+10% +$92.1K 0.13% 194
2021
Q2
$690K Buy
22,520
+332
+1% +$10.2K 0.1% 263
2021
Q1
$544K Sell
22,188
-1,338
-6% -$32.8K 0.09% 278
2020
Q4
$611K Buy
23,526
+6
+0% +$156 0.13% 217
2020
Q3
$607K Sell
23,520
-370
-2% -$9.55K 0.14% 184
2020
Q2
$585K Buy
23,890
+6,580
+38% +$161K 0.15% 187
2020
Q1
$521K Buy
17,310
+1,062
+7% +$32K 0.18% 161
2019
Q4
$470K Buy
+16,248
New +$470K 0.12% 229
2019
Q1
Sell
-2,004
Closed -$46K 1227
2018
Q4
$46K Buy
+2,004
New +$46K 0.02% 656
2018
Q1
$56K Sell
2,288
-1,400
-38% -$34.3K 0.03% 585
2017
Q4
$99K Buy
+3,688
New +$99K 0.05% 440